Emerging trends: The impact of COVID-19 on API manufacturing and supply

As an industry, we are continuing to adjust to the global challenges faced during the COVID-19 pandemic and it is widely acknowledged that this will be felt in the pharmaceutical industry for some time to come. Supply issues lead India to invest in local manufacturing...

Synairgen Releases Positive Results from Breakthrough Coronavirus Treatment

Synairgen, the respiratory drug discovery and development company which originated from research at the University of Southampton, has released positive results from its clinical trial of SNG001...

Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine

Bavarian Nordic announced the signing of an agreement with AdaptVac, a joint venture established by ExpreS2ion Biotechnologies and NextGen Vaccines spun out of the University of Copenhagen...

SGS to provide analytical testing for AstraZenecas Covid-19 vaccine

SGS will provide its services to support the development of AstraZeneca's Covid-19 vaccine candidate AZD1222 which was co-invented by the University of Oxford and its spin-out company...

Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19

Novartis announced a new initiative to help patients in low-income and lower-middle-income countries access affordable medicines to treat the major...

Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

U.S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 600 million additional doses...

Thermo Fisher Scientific Launches Industry Leading Offering to Facilitate cGMP Compatible Cell and Gene Therapy Manufacturing

Thermo Fisher Scientific announces the launch of an industry leading product, compliance and services portfolio, compatible with cGMP and designed...

Lilly's Mirikizumab Superior to Cosentyx in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis

Eli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the primary...

Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA in Patients Treated with Zolgensma

Biogen Inc announced it plans to initiate a global Phase 4 clinical study, RESPOND, to examine the clinical benefit and assess the safety of SPINRAZA...

BioInvent's BI-1206 could improve treatment in several cancers

Alexander Eggermont, MD, PhD, Chief Scientific Officer at the Princess Máxima Center and renowned expert in immunotherapy showcased the broad potential...

Seven Indian Drugmakers Race To Develop Covid-19 Vaccine

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E among domestic pharma firms working on the vaccines in India.